top of page
.jpg){kind=logo}
Recent News
Vivacelle Bio to Participate in BIO Partnering @ JPM Week 2025
Vivacelle Bio , a late-stage biopharma company developing life-saving treatments for shock and trauma, announced its participation in BIO...
Selective nitric oxide redistribution by phospholipid nanoparticles: A novel strategy to mitigate massive nitric oxide release and prevent reperfusion injury in septic shock
Free Radical Biology and Medicine Volume 227 , 1 February 2025, Pages 276-281 https://www.sciencedirect.com/science/article/abs/pii/S0891...
Vivacelle Bio Commemorates Sepsis Awareness Month, Recognizing the Leading Cause of Death in U.S. Hospitals
KANSAS CITY, Mo., Sept. 24, 2024 /PRNewswire/ -- Vivacelle Bio , a late-stage biopharma company developing life-saving treatments for...
1 min read
Vivacelle Bio named included in 101 top Illinois Biotechnology Companies and Startups - 2021
Vivacelle Bio named included in 101 top Illinois Biotechnology Companies and Startups - 2021 https://beststartup.us/101-top-illinois-biot...
3 min read
World Sepsis Pipeline Insight 2021: Pipeline Product Profiles, Therapeutic Assessment, Pipeline Assessment, Inactive Drugs Assessment, Unmet Needs
February 09, 2021 09:24 AM Eastern Standard Time DUBLIN--(BUSINESS WIRE)--The "Sepsis Pipeline Insight 2021" drug pipelines has been...
2 min read
Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens
NEWS PROVIDED BY Vivacelle Bio, Inc. 24 Nov, 2020, 08:00 ET FORT WAYNE, Ind., Nov. 24, 2020 /PRNewswire/ -- Vivacelle Bio, Inc. today...
1 min read
Vivacelle Bio Given the Business Expansion Award by the Metro Chamber Alliance of Greater Fort Wayne
April 29, 2020 - VIVACELLE BIO GIVEN THE BUSINESS EXPANSION AWARD BY THE METRO CHAMBER ALLIANCE OF GREATER FORT WAYNE
1 min read
VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients
See Trial Information here: https://clinicaltrials.gov/study/NCT04257136?tab=table
1 min read
Vivacelle Bio Provides its Sepsis Treatment for COVID-19 Via Compassionate Use
April 22, 2020 Vivacelle Biosciences said it will make its experimental sepsis treatment VBI-S available for compassionate use in...
3 min read
Vivacelle Bio Announces Compassionate Use for COVID-19 Patients with Its Sepsis Treatment, VBI-S
Most COVID patients die of septic shock. In early studies VBI-S improved blood pressure and oxygenation of septic shock patients when all...
2 min read
Vivacelle Bio granted IND
February 15, 2019 CHICAGO--(BUSINESS WIRE)--Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has...
0 min read
bottom of page